As the rising drug price issue has taken hold of the healthcare debate in the U.S., Democrats in Congress have introduced a bill that would allow Medicare to negotiate drug prices. 

President Trump’s second annual State of the Union speech was held on Feb. 5, during which the president touched on many subjects, including several healthcare goals and changes. 

Since CMS proposed expanding supplemental benefits for Medicare Advantage for the 2020 plan year, several industry groups have voiced their support, seeing opportunities to improve care for individuals with chronic illnesses and lower costs.

HHS has proposed lowering drug costs by targeting the rebate system, which has recently come under scrutiny as an opaque setup that keeps drug prices high.

E-cigarettes may actually help smokers quit, according to a recent study in the New England Journal of Medicine.

CMS has proposed expanding supplemental benefits in Medicare Advantage plans to include any benefit that “improves or maintains health,” particularly for the chronically ill population, the agency announced Jan. 30. MA plans will be able to more freely offer benefits such as meals and home modifications to better serve members with certain conditions.

Mandating pharmaceutical companies to disclose drug prices as part of Direct-to-Consumer Pharmaceutical Advertising (DTCPA) may reduce consumer interest in high-priced drugs. But the inclusion of modifiers indicating consumers will have zero out-of-pocket costs weakened the finding, according to the results of a behavioral experiment published in JAMA Internal Medicine. 

The U.S. government shutdown, which is now the longest-running in history, could potentially harm consumers and undermine the stability of the Affordable Care Act healthcare insurance market, The Wall Street Journal reported.

As progressive Democrats increasingly push for universal healthcare, known as Medicare for all, support for such a plan is mixed when it comes to paying for it, according to a recent poll from the Kaiser Family Foundation.

More industry groups are pushing back against an upcoming deadline for accountable care organizations (ACOs) to apply to the updated Medicare Shared Savings Program.

Medicare payments in 2019 aren’t likely to cover the cost of delivering care for two-thirds of medical practices, according to a survey from the Medical Group Management Association (MGMA).

Many Americans with disabilities and pre-existing conditions are concerned about their future if a ruling that overturns the Affordable Care Act remains in place.